Viewing StudyNCT02400255



Ignite Creation Date: 2024-05-06 @ 3:53 AM
Last Modification Date: 2024-10-26 @ 11:40 AM
Study NCT ID: NCT02400255
Status: COMPLETED
Last Update Posted: 2023-12-18
First Post: 2015-03-18

Brief Title: Crenolanib Maintenance Following Allogeneic Stem Cell Transplantation in FLT3-positive Acute Myeloid Leukemia Patients
Sponsor: Arog Pharmaceuticals Inc
Organization: Arog Pharmaceuticals Inc

Key Dates - Follows AllAPIJSON File Order

Start Date: 2015-09
Start Date Type: ACTUAL
Primary Completion Date: 2022-05
Primary Completion Date Type: ACTUAL
Completion Date: 2022-05
Completion Date Type: ACTUAL
First Submit Date: 2015-03-18
First Submit QC Date: March 23 2015
Study First Post Date: 2015-03-27
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: 2023-12-18
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-12-13
Last Update Post Date: 2023-12-18
Last Update Post Date Type: ACTUAL